CompanyDrug

VivaVision Biotech’s VVN539 Enters Phase II Trial for Open-Angle Glaucoma in US

CompanyDeals

Science Sun Pharma and Mabworks Biotech Sign Strategic Cooperation Pact

CompanyDeals

Hangzhou DAC Bio Partners with Janssen on ADC Development Deal

Policy / Regulatory

NHSA Sets 2022 Goals for Basic Medical Insurance Funding and Reforms

CompanyDrug

Neurophth’s NR082 Gene Therapy Receives BTD for Leber Hereditary Optic Neuropathy

CompanyDrug

Biotheus Inc.’s PM1009 Bispecific Antibody Enters Clinical Trial Review for Solid Tumors

CompanyDeals

Rainmed Medical Makes IPO Debut on Hong Kong Exchange with Valuation Over USD 764M

CompanyDeals

MicuRx Pharmaceuticals Approved for STAR Market IPO by CSRC

CompanyDrug

Innovent Biologics’ Pemazyre Becomes First FGFR2 Inhibitor Approved in China

CompanyDrug

Dizal Pharma’s DZD1516 Receives NMPA Green Light for HER2+ Breast Cancer Trial

CompanyDeals

WuXi XDC Partners with AbTis to Advance ADC Development and Manufacturing

CompanyDrug

GenScript Biotech’s Legend Biotech Terminates LB1901 CAR-T Phase I Trial